Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752114 · ClinicalTrials.gov registry record
Early Diagnosis of Pulmonary Nodules
A clinical trial of Carcinoma and Precancerous Conditions, sponsored by Integrated Diagnostics.
- Completed
- Registry status
- 684
- Enrollment target
- 20
- Study locations
NCT01752114 is a study of Carcinoma and Precancerous Conditions that has completed, run by Integrated Diagnostics. The registered enrollment target is 684 participants, above the 231-participant average among 29 other Carcinoma trials with a reported enrollment target (196% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT01752114, a study of Carcinoma and Precancerous Conditions, has completed, sponsored by Integrated Diagnostics.
- COMPLETED
- Registry status
- 684 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.
Conditions Studied
Study Locations (20)
North Carolina
- Charleston Research Institute - Charleston
- Carolinas HealthCare System - Charlotte
- LeBaurer Healthcare - Greensboro
Arizona
- St. Joseph's Hospital & Medical Center - Phoenix
- Pulmonary Associates of Southern Arizona - Tucson
California
- University of Southern California - Los Angeles
- California Pacific Medical Center - San Francisco
Maryland
- Pulmonary & Crit Care Associates of Baltimore - Baltimore
- Johns Hopkins Medical Center - Baltimore
Michigan
- Henry Ford Hospital - Detroit
- Beaumont Health System - Royal Oak
Minnesota
- Virginia Piper Cancer Institute - Allina Health - Minneapolis
- Mayo Clinic - Rochester
Florida
- Sarasota Memorial Hospital - Sarasota
Georgia
- Georgia Lung Associates - Austell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 684 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01752114
The ClinicalTrials.gov registry entry for NCT01752114 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 684 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 231-participant average among 29 other Carcinoma trials with a reported enrollment target (196% higher). The listed sponsor is Integrated Diagnostics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT01752114 reports 20 study locations spanning 13 distinct geographic areas - top geographies include North Carolina, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT01752114 about?
NCT01752114 is a clinical study titled "Early Diagnosis of Pulmonary Nodules". This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.
What is the current status of trial NCT01752114?
This trial is currently completed. The enrollment target is 684 participants. The study started on 2012-10. Estimated completion is 2016-12-31.
What conditions does trial NCT01752114 study?
This clinical trial studies the following conditions: Carcinoma, Precancerous Conditions.
Who is sponsoring clinical trial NCT01752114?
This trial is sponsored by Integrated Diagnostics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01752114 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
RECRUITING · Early Phase 1
-
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy
RECRUITING · Phase 2
-
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
RECRUITING · Phase 2
-
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
RECRUITING · Phase 1
-
Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.